Retina · 2010 · 31 citations · 30 references
MedicineOphthalmologyPharmacologyClinical Vision ScienceOcular DiseaseOcular PharmacologyDiabetic RetinopathyMacular DiseaseMacular DisordersMedication Effects On VisionRetinal PharmacotherapyVisual Loss EvaluationDiabetic Retinopathy Vision LossFluorescein Angiography FindingsMacular Edema AssessmentMacular Edema EvaluationMacular Edema TreatmentMacular Optical Coherence TomographyPlacebo ComparatorsVisual Function Loss
In Brief Purpose: Inflammation may play an important role in the pathogenesis of diabetic macular edema, a major cause of vision loss in persons with diabetes. The purpose of this study was to evaluate combined antiinflammatory therapy and laser approaches for treating patients with diabetic macular edema. Methods: In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema. The primary outcome is change in visual acuity of ≥15 letters from baseline, and the secondary outcomes include a 50% reduction in the retinal thickening of diabetic macular edema measured by optical coherence tomography and a 50% reduction in leakage severity on fluorescein angiography. Results: Visual acuity and retinal thickening data from >2 years of follow-up did not show evidence of differences between the medical and laser treatments. However, participants assigned to the celecoxib group were more likely to have a reduction in fluorescein leakage when compared with the placebo group (odds ratio = 3.6; P < 0.01). Conclusion: This short-term study did not find large visual function benefits of treatment with celecoxib or diode laser compared with those of standard laser treatment. A suggestive effect of celecoxib in reducing fluorescein leakage was observed. A randomized controlled trial of treatment of diabetic macular edema with Celecoxib (Celebrex) and laser treatment (micropulse laser vs. Early Treatment Diabetic Retinopathy Study focal therapy) found a greater decrease in fluorescein angiography leakage with the COX-2 inhibitor.
30
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
Archives of Ophthalmology · 2004 · 2.6K citations · Full text
Medicine, Demography, Ophthalmology +17
Photocoagulation for Diabetic Macular Edema
Archives of Ophthalmology · 1985 · 2.5K citations
New Visual Acuity Charts for Clinical Research
Frederick L. Ferris, Aaron Kassoff, George H. Bresnick et al. · American Journal of Ophthalmology · 1982 · 2.2K citations
Medicine, Ophthalmology, Optometry +11